Praxair, Inc. (PX) Tops Q2 EPS by 1c; Boosts FY11 EPS Outlook, Guides Q3
Tweet
Share
E-mailGet Alerts PX Hot Sheet
Join SI Premium – FREE
Praxair, Inc. (NYSE: PX) reported Q2 EPS of $1.38, $0.01 better than the analyst estimate of $1.37. Revenue for the quarter came in at $2.86 billion versus the consensus estimate of $2.79 billion.
Sees FY2011 EPS of $5.40-$5.50, versus the consensus of $5.47.
Praxair sees Q311 EPS of $1.35-$1.40, versus the consensus of $1.39.
Sees FY2011 EPS of $5.40-$5.50, versus the consensus of $5.47.
Praxair sees Q311 EPS of $1.35-$1.40, versus the consensus of $1.39.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- Creative Medical Technology issues mid-year pipeline update
- Biogen expects $164M R&D charge to hit Q2 2026 earnings
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
